Earth Science Tech, Inc. is a biotechnology and consumer health company specializing in the research, development and commercialization of phytocannabinoid-based products. Since its founding in the mid-2000s, the company has focused on formulating water-soluble, nano-emulsified cannabinoid and botanical extracts designed to maximize bioavailability and therapeutic potential. Its R&D efforts emphasize advanced delivery systems that support rapid absorption and consistent dosing across nutritional supplements, pharmaceuticals and personal care applications.
The company’s flagship product lines include nutraceutical formulations for wellness support, topical solutions for skincare and pain management, and proprietary pharmaceutical candidates targeting cognitive health and neurological disorders. Earth Science Tech has obtained multiple patents covering its nano-emulsion technologies and collaborates with academic institutions to explore novel uses of non-psychoactive cannabinoids. In addition to in-house manufacturing capabilities, the company partners with contract manufacturers and GMP-certified facilities to scale production and maintain stringent quality controls.
Earth Science Tech distributes its products through diverse channels, including direct-to-consumer e-commerce, select retail outlets in North America and strategic partnerships in Europe and Asia. The company has established regional distribution agreements to introduce its formulations into health clinics, pharmacies and specialty wellness centers. Recent expansion initiatives have targeted emerging markets in the Asia-Pacific region, leveraging local regulatory approvals and growing consumer interest in plant-derived therapies.
Led by Chief Executive Officer Michael V. Apple, Earth Science Tech’s management team combines expertise in pharmaceutical development, botanical extraction and global business strategy. The board includes seasoned professionals in finance, regulatory affairs and life science commercialization. Throughout its history, the company has pursued a balanced approach of rigorous scientific validation and agile market entry, aiming to position its cannabinoid-based technologies at the intersection of health care innovation and consumer wellness trends.
AI Generated. May Contain Errors.
